Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase III, Randomized, Double-Blinded, Multi-Center, Study to Assess the Efficacy of Docetaxel (TAXOTERE™) in Combination With ZD6474 (ZACTIMA™) Versus Docetaxel (TAXOTERE™) With Placebo in Subjects With Locally Advanced or Metastatic NSCLC
Vandetanib, Docetaxel
D4200C00032
NCT00312377
EudraCT2005-004749-32
Non-Small Cell Lung Cancer
Phase 3
 
Datasets and document are available as per Sanofi Policy and criteria
May 2017

Powered by ideaPoint, Inc.